[1] Palus S,von Haehling S,Springer J.Muscle wasting:An overview of recent developments in basic research[J].J Cachexia Sarcopenia Muscle,2014,5(3):193-198.
[2] Shenhav C,Nathan J A,Goldberg A L.Muscle wasting in disease:Molecular mechanisms and promising therapies[J].Nat Rev Drug Discov,2015,14(1):58-74.
[3] Londhe P,Guttridge D C.Inflammation induced loss of skeletal muscle[J].Bone,2015,80:131-142.
[4] Hasselgren P O,Fischer J E.Counter-regulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle[J].Curr Opin Clin Nutr Metab Care,1999,2(1):9-14.
[5] Hanaoka B Y,Peterson C A,Horbinski C,et al.Implications of glucocorticoid therapy in idiopathic inflammatory myopathies[J].Nat Rev Rheumatol,2012,8(8):448-457.
[6] Smith I J,Alamdari N,O'Neal P,et al.Sepsis increases the expression and activity of the transcription factor Forkhead BoxO 1(FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism[J].Int J Biochem Cell Biol,2010,42(5):701-711.
[7] Braun T P,Grossberg A J,Krasnow S M,et al.Cancer and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle[J].FASEB J,2013,27(9):3572-3582.
[8] Vary T C.Regulation of skeletal muscle protein turnover during sepsis[J].Curr Opin Clin Nutr Metab Care,1998,1(2):217-224.
[9] Li Y P,Chen Y,John J,et al.TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle[J].FASEB J,2005,19(3):362-370.
[10] Orellana R A,O'Connor P M,Nguyen H V,et al.Endotoxemia reduces skeletal muscle protein synthesis in neonates[J].Am J Physiol Endocrinol Metab,2002,283(5):E909-916.
[11] Frost R A,Nystrom G J,Lang C H.Endotoxin and interferon-gamma inhibit translation in skeletal muscle cells by stimulating nitric oxide synthase activity[J].Shock,2009,32(4):416-426.
[12] Russell S T,Siren P M,Siren M J,et al.Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myoinositol 1,2,6-triphosphate[J].Exp Cell Res,2010,316(2):286-295.
[13] Tarabees R,Hill D,Rauch C,et al.Endotoxin transiently inhibits protein synthesis through Akt and MAPK mediating pathways in C2C12 myotubes[J].Am J Physiol Cell Ph,2011,301(4):C895-902.
[14] Bilir C,Engin H,Can M,et al.The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia[J].Med Oncol,2015,32(3):1-6.
[15] Ermina B,Nielsen R R,Vendelbo M H,et al.Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo-controlled,bilaterally infused human leg:Increased insulin sensitivity,increased net protein breakdown,and increased IL-6 release[J].Diabetes,2013,62(12):4023-4029.
[16] Zhou J,Liu B,Liang C,et al.Cytokine signaling in skeletal muscle wasting[J].Trends Endocrinol Metab,201627(5):335-347.
[17] Subramaniam K,Fallon K,Ruut T,et al.Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease[J].Aliment Pharmacol Ther,2015,41(5):419-428.
[18] Claude L.Cytokine anniversary:TNF trailblazers five centuries apart[J].Nature,2015,523(7559):158.
[19] Wajant H,Scheurich P.TNFR1-induced activation of the classical NF-kappaB pathway[J].FEBS J,2011,278(6):862-876.
[20] Wang J,Allamki R S.Tumor necrosis factor receptor 2:Its contribution to acute cellular rejection and clear cell renal carcinoma[J].Biomed Res Int,2013,2013(1):821310.
[21] Pedersen B K,Febbraio M A.Muscles,exercise and obesity:Skeletal muscle as a secretory organ[J].Nat Rev Endocrinol,2012,8(8):457-465.
[22] Batista M L,Olivan M,Alcantara P S,et al.Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients[J].Cytokine,2013,61(2):532-539.
[23] Suh S Y,Choi Y S,Chang H Y,et al.Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer[J].Support Care Cancer,2013,21(11):3071-3077.
[24] Mueller T C,Bachmann J,Prokopchuk O,et al.Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia-can findings from animal models be translated to humans?[J].BMC Cancer,2016,16(1):1-14.
[25] Baltgalvis K A,Berger F G,Peña M M,et al.Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic ApcMin/+ mouse[J].Pflugers Arc,2009,457(5):989-1001.
[26] White J P,Baynes J W,Welle S L,et al.The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the ApcMin/+ mouse[J].PLoS One,2011,6(9):e24650.
[27] Silva K A,Dong J,Dong Y,et al.Inhibition of stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system,leading to preservation of muscle mass in cancer cachexia[J].J Biol Chem,2015,290(17):11177-11187.
[28] Bonetto A,Aydogdu T,Jin X,et al.JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia[J].Am J Physiol Endocrinol Metab,2012,303(3):E410-421.
[29] Hindi S M,Mishra V,Bhatnagar S,et al.Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program[J].FASEB J,2014,28(3):1398-1411.
[30] Padrão A I,Moreira-Gonçalves D,Oliveira P A,et al.Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia[J].Arch Biochem Biophys,2015,567:13-21.
[31] Mittal A,Bhatnagar S,Kumar A,et al.The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice[J].J Cell Biol,2010,188(6):833-849.
[32] Paul P K,Gupta S K,Bhatnagar S,et al.Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice[J].J Cell Biol,2010,191(7):1395-1411.
[33] Wissing E R,Boyer J G,Kwong J Q,et al.P38α MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism[J].Hum Mol Genet,2014,23(20):5452-5463.
[34] Bernet J D,Doles J D,Hall J K,et al.p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice[J].Nat Med,2014,20(3):265-271.
[35] Madrigalmatute J,Fernandezlaso V,Sastre C,et al.TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages[J].Cardiovasc Res,2015,108(1):139-147.
[36] Derbré F,Gratas-Delamarche A.Inactivity-induced oxidative stress:A central role in age-related sarcopenia[J].Eur J Sport Sci,2014,14(Sup1):S98-S108.
[37] Bechara L R,Moreira J B,Jannig P R,et al.NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats[J].Int J Cardiol,2014,175(3):499-507.
[38] Rom O,Reznick A Z.The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass[J].Free Radic Biol Med,2016,Epub ahead of print.
[39] Lecker S H,Jagoe R T,Gilbert A,et al.Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression[J].FASEB J,2004,18(1):39-51.
[40] Bodine S C,Baehr L M.Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1[J].Am J Physiol Endocrinol Metab,2014,307(6):E469-484.
[41] Dehoux M J,van Beneden R P,Fernandez-Celemin L,et al.Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection[J].FEBS Lett,2003,544(1-3):214-217.
[42] Lagirand-Cantaloube J,Cornille K,Csibi A,et al.Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo[J].PLoS One,2009,4(3):e4973.
[43] Lagirand-Cantaloube J,Offner N,Csibi A,et al.The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy[J].EMBO J,2008,27(8):1266-1276.
[44] Jamart C,Raymackers J M,Li An G,et al.Prevention of muscle disuse atrophy by MG132 proteasome inhibitor[J].Muscle Nerve,2011,43(5):708-716.
[45] Caron A Z,Haroun S,Leblanc E,et al.The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice[J].BMC Musculoskel Dis,2011,12:185.
[46] Price S R,Bailey J L,Wang X,et al.Muscle wasting in insulinopenic rats results from activation of the ATP-dependent,ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription[J].J Clin Invest,1996,98(8):1703-1708.
[47] Kwon Y T,Xia Z,Davydov I V,et al.Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1(E3alpha) of the N-end rule pathway[J].Mol Cell Biol,2001,21(23):8007-8021.
[48] Dehoux M,Van Beneden R,Pasko N,et al.Role of the insulin-like growth factorⅠdecline in the induction of atrogin-1/MAFbx during fasting and diabetes[J].Endocrinology,2004,145(11):4806-4812.
[49] Yang Z,Klionsky D J.Mammalian autophagy:Core molecular machinery and signaling regulation[J].Curr Opin Cell Biol,2010,22(2):124-131.
[50] Masiero E,Agatea L,Mammucari C,et al.Autophagy is required to maintain muscle mass[J].Cell Metab,2009,10(6):507-515.
[51] Aucello M,Dobrowolny G,Musaro A.Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway[J].Autophagy,2009,5(4):527-529.
[52] Mizushima N,Yamamoto A,Matsui M,et al.In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker[J].Mol Biol Cell,2004,15(3):1101-1111.
[53] Zhao J,Brault J J,Schild A,et al.FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells[J].Cell Metab,2007,6(6):472-483.
[54] Mammucari C,Milan G,Romanello V,et al.FoxO3 controls autophagy in skeletal muscle in vivo[J].Cell Metab,2007,6(6):458-471.
[55] McClung J M,Judge A R,Powers S K,et al.p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting[J].Am J Physiol Cell Physiol,2010,298(3):C542-549.
[56] Doyle A,Zhang G,Abdel Fattah E A,et al.Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways[J].FASEB J,2011,25(1):99-110.
[57] Duan C,Ren H,Gao S.Insulin-like growth factors (IGFs),IGF receptors,and IGF-binding proteins:Roles in skeletal muscle growth and differentiation[J].Gen Comp Endocrinol,2010,167(3):344-351.
[58] Morissette M R,Cook S A,Buranasombati C,et al.Myostatin inhibits IGF-1-induced myotube hypertrophy through Akt[J]. Am J Physiol Cell Ph,2009,297(5):C1124-1132.
[59] Trendelenburg A U,Meyer A,Rohner D,et al.Myostatin reduces Akt/TORC1/p70S6K signaling,inhibiting myoblast differentiation and myotube size[J].Am J Physiol Cell Ph,2009,296(6):C1258-1270.
[60] Amirouche A,Durieux A C,Banzet S,et al.Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle[J].Endocrinology,2009,150(1):286-294.
[61] Arden K C.FOXO animal models reveal a variety of diverse roles for FOXO transcription factors[J].Oncogene,2008,279(16):2345-2350.
[62] Stitt T N,Drujan D,Clarke B A,et al.The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors[J].Mol Cell,2004,14(3):395-403.
[63] Crossland H,Constantin-Teodosiu D,Gardiner S M,et al.A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle[J].J Physiol,2008,586(Pt 22):5589-5600.
[64] Russell S T,Eley H L,Wyke S M,et al.Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor[J].Biochem J,2008,409(3):751-759.
[65] Wyke S M,Khal J,Tisdale M J.Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes[J].Cell Signal,2005,17(1):67-75.
[66] Wu M,Falasca M,Blough E R.Akt/protein kinase B in skeletal muscle physiology and pathology[J].J Cell Physiol,2011,226(1):29-36.
[67] Jin B,Li Y P.Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss[J].J Cell Biochem,2007,100(4):960-969.
[68] Cai D,Frantz J D,Tawa N E,et al.IKKbeta/NF-kappaB activation causes severe muscle wasting in mice[J].Cell,2004,119(2):285-298.
[69] Langen R C,Haegens A,Vernooy J H,et al.NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy[J].Am J Respir Cell Mol Biol,2012,47(3):288-297.
[70] Ladner K J,Caligiuri M A,Guttridge D C.Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products[J].J Biol Chem,2003,278(4):2294-2303.
[71] 王彩云,张春香,贾广乐.n-3多不饱和脂肪酸与免疫细胞信号转导[J].中国畜牧兽医,2007,34(10):25-27.
[72] 刘观忠,安胜英.多不饱和脂肪酸对家禽免疫机能的影响[J].中国畜牧兽医,2012,39(5):95-98.
[73] 英永,陈继兰,郑麦青,等.不同ω6/ω3多不饱和脂肪酸日粮对AA肉鸡脂多糖免疫应激的影响[J].中国畜牧兽医,2008,35(12):11-15.
[74] Liu Y H,Li X Y,Chen C Y,et al.Omega-3 fatty acid intervention suppresses lipopolysaccharide-induced inflammation and weight loss in mice[J].Mar Drugs,2015,13(2):1026-1036.
[75] Liu Y,Chen F,Odle J,et al.Fish oil increases muscle protein mass and modulates Akt/FOXO,TLR4,and NOD signaling in weanling piglets after lipopolysaccharide challenge[J].J Nutr,2013,143(8):1331-1339.
[76] Chen P Y,Sun H L,Lin Y C,et al.18-Carbon polyunsaturated fatty acids via down-regulation NF-κB activation reduce lipopolysaccharide-induced myotube atrophy[J].Rsc Advances,2016,6(28):23581-23587.
[77] Nicastro H,da Luz C R,Chaves D F,et al.Does branched-chain amino acids supplementation modulate skeletal muscle remodeling through inflammation modulation? Possible mechanisms of action[J]. J Nutr Metab,2012,2012:136937.
[78] Zhang B,Yu C,Lin M,et al.Regulation of skeletal muscle protein synthetic and degradative signaling by alanyl-glutamine in piglets challenged with Escherichia coli lipopolysaccharide[J].Nutrition,2015,31(5):749-756.
[79] Senf S M,Dodd S L,McClung J M,et al.Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy[J].FASEB J,2008,22(11):3836-3845.
[80] Dodd S L,Hain B,Senf S M,et al.Hsp27 inhibits IKKβ-induced NF-κB activity and skeletal muscle atrophy[J].FASEB J,2009,23(10):3415-3423. |